Skip to main content
Osh project, fighting TB
War in Gaza:: find out how we're responding
Learn more
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.3 million people in 2022, TB is the world’s second deadliest infectious disease after COVID-19.

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. In 2022, 7.5 million people across 192 countries and areas were diagnosed with TB.
 
Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10.6 million people fell sick with TB and 410,000 developed multidrug-resistant TB (MDR-TB) in 2022, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2021. The majority go undiagnosed and therefore untreated.

Tuberculosis

Quick facts about tuberculosis

 
Tuberculosis

EndTB: Bedaquiline- and delamanid- containing regimens achieve excellent interim treatment response without safety concerns

endtb.org 13 Jul 2018
 
Tuberculosis

TB Online: Activists call on Johnson & Johnson to drop the price of bedaquiline

tbonline.info 13 Jul 2018
 
TB support in Swaziland
Eswatini

MSF hands over its Manzini project, while continuing activities in Shiselweni

Statement 25 Jun 2018
 
The Stop Stocks Outs Project South Africa April 2015
South Africa

Country takes landmark step for access to medicines

Press Release 31 May 2018
 
Journal article

Conflict and tuberculosis in Sudan

16 May 2018
Journal article
 
Journal article

Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

1 May 2018
Journal article
 
Journal article

Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review

6 Apr 2018
Journal article
 
Journal article

Breast tuberculosis in men: A systematic review

3 Apr 2018
Journal article
 
Journal article

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

1 Apr 2018
Journal article
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB